The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and other medical products. The contract has a base period of one year from April 30, 2023 to April 29, 2024, with four one-year option periods, for a total potential value of $22,774,781.20.
The contract is for the supply of Carvedilol tablets in various dosages to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. Orders will be placed against the contract through the VA's and DOD's respective Pharmaceutical Prime Vendor Programs. The contract was competitively awarded without any set-aside designations, and leverages Golden State Medical Supply's distribution infrastructure to supply the required pharmaceutical products to various government healthcare facilities on an as-needed basis.
Generated 4/10/24, 9:18 AM